Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum

Journal of Infectious Diseases

Volumn 174, Issue 2, 1996, Pages 367-372

  Alonso, Pedro L ^a   Smith, Tom A ^b   Armstrong Schellenberg, Joanna R M ^b   Kitua, Andrew Y ^b   Masanja, Honorathi ^b   Hayes, Richard ^b   Hurt, Nicole ^b   Font, Fidel ^b   Menendez, Clara ^b   Kilama, Wencislaus L ^b   Tanner, Marcel ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FANSIDAR; MALARIA VACCINE; PLACEBO;

AFRICA; AGE; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; PARASITEMIA; PLASMODIUM FALCIPARUM; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

EID: 8944256083     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.2.367     Document Type: Article

References (20)

1. Alonso PL, Molyneux ME, Smith T. Design and methodology of field-based intervention trials of malaria vaccines. Parasitol Today 1995;11:197-200.
2. Moreno A, Patarroyo ME. Development of an asexual blood stage malaria vaccine. Blood 1989;74:537-46.
3. Valero MV, Amador LR, Galindo C, et al. Vaccination with SPf66, a chemically synthesized vaccine, against Plasmodium falciparum malaria in Colombia. Lancet 1993;341:705-10.
4. Noya O, Gabaldon BY, Alarcon de Noya B, et al. A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela. J Infect Dis 1994;170:396-402.
5. Sempertegui F, Estrella B, Moscoso F, et al. Safety, immunogenicity, and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double blind placebo controlled field trial in an endemic area of Ecuador. Vaccine 1994;12:337-42.
6. Teuscher T, Armstrong-Schellenberg JRM, Bastos de Azevedo I, et al. SPf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmission. Vaccine 1994;12:328-36.
7. Alonso PL, Smith T, Armstrong-Schellenberg JRM, et al. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in children in southern Tanzania. Lancet 1994;343:1175-81.
8. D'Alessandro U, Leach A, Drakeley CJ, et al. Efficacy trial of malaria vaccine SPf66 in Gambian infants. Lancet 1995;346:462-7.
9. Tanner M, De Savigny D, Mayombana C, et al. Morbidity and mortality at Kilombero, Tanzania, 1982-1988. In: Feachem RG, Jamison DT, eds. Disease and mortality in sub-Saharan Africa. Oxford: Oxford University Press, 1991:286-305.
10. Alonso PL, Tanner M, Smith T, et al. A trial of the synthetic malaria vaccine SPf66 in Tanzania: rationale and design. Vaccine 1994;12:181-6.
11. Statistics and Epidemiology Research Corporation. EGRET: user's manual. Seattle: SERC, 1991.
12. Pierce DA, Sands BR. Extra-Bernouilli variation in binary data. Corvallis, OR: Department of Statistics, Oregon State University, 1975; technical report no. 46.
13. Searle SR, Speed FM, Milliken GA. Population marginal means in the linear model: an alternative to least squares means. Am Statistician 1980;34:216-21.
14. Patterson HD, Thompson R. Recovery of inter-block information when block sizes are unequal. Biometrika 1974;58:545-54.
15. SAS Institute. SAS/STAT software: changes and enhancements, release 6.07. Cary, NC: SAS Institute, 1992; SAS technical report no. P-229.
16. Trape JF, Rogier C. Efficacy of SPf66 vaccine against malaria in children. Lancet 1995;345:134.
17. Alonso PL, Smith T, Tanner M. Efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children. Lancet 1995;345:135.
18. Patarroyo ME, Romero P, Torres ML, et al. Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature 1987;328:629-32.
19. Patarroyo ME, Amador R, Clavijo P, et al. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum. Nature 1988;332:158-61.
20. Tanner M, Teuscher T, Alonso PL. The first malaria vaccine. Parasitol Today 1995;11:10-3.